Follow
Ravendra Garg
Ravendra Garg
Vaccine infectious disease organization, U of S
Verified email at usask.ca
Title
Cited by
Cited by
Year
Animal models for vaccine studies for visceral leishmaniasis
R Garg, A Dube
Indian Journal of Medical Research 123 (3), 439-454, 2006
2002006
Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator …
S Garlapati, R Garg, R Brownlie, L Latimer, E Simko, RE Hancock, ...
Vaccine 30, 5206-5214, 2012
83*2012
van Drunen Littel-van den Hurk, S. Selection of adjuvants for vaccines targeting specific pathogens
I Sarkar, R Garg
Expert Rev. Vaccines 18 (5), 505-521, 2019
792019
Leishmania infantum Amastigotes Enhance HIV-1 Production in Cocultures of Human Dendritic Cells and CD4+ T Cells by Inducing Secretion of IL-6 and TNF-α
R Garg, C Barat, M Ouellet, R Lodge, MJ Tremblay
PLoS neglected tropical diseases 3 (5), e441, 2009
592009
Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a …
R Garg, SK Gupta, P Tripathi, S Naik, S Sundar, A Dube
Clinical & Experimental Immunology 140 (1), 149-156, 2005
582005
Selection of adjuvants for vaccines targeting specific pathogens
I Sarkar, R Garg, S van Drunen Littel-van den Hurk
Expert Review of Vaccines 18 (5), 505-521, 2019
572019
Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral …
R Garg, SK Gupta, P Tripathi, K Hajela, S Sundar, S Naik, A Dube
Vaccine 24 (15), 2900-2909, 2006
552006
The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development
R Garg, P Shrivastava, S van Drunen Littel-van den Hurk
Expert review of vaccines 11 (12), 1441-1457, 2012
512012
Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity
R Garg, L Latimer, V Gerdts, A Potter, S van Drunen Littel-van den Hurk
Journal of General Virology 95 (5), 1043-1054, 2014
492014
Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation
R Garg, L Latimer, E Simko, V Gerdts, A Potter, ...
Journal of General Virology 95 (2), 301-306, 2014
472014
Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis
SK Sharma, A Dube, A Nadeem, S Khan, I Saleem, R Garg, ...
Vaccine 24 (11), 1800-1810, 2006
452006
A novel combination adjuvant platform for human and animal vaccines
R Garg, L Babiuk, V Gerdts
Vaccine 35 (35), 4486-4489, 2017
382017
Indolamine 2, 3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients
S Schulz, A Landi, R Garg, JA Wilson, S van Drunen Littel-van den Hurk
Clinical & Experimental Immunology 180 (3), 484-498, 2015
332015
Type of multimorbidity and patient-doctor communication and trust among elderly Medicare beneficiaries
R Garg, C Shen, N Sambamoorthi, K Kelly, U Sambamoorthi
International journal of family medicine 2016, 2016
312016
225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models
R Garg, KJH Allen, W Dawicki, EM Geoghegan, DL Ludwig, E Dadachova
Cancer Medicine 10 (3), 1128-1140, 2021
302021
Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs
R Garg, L Latimer, Y Wang, E Simko, V Gerdts, A Potter
Vaccine 34 (2), 261-269, 2016
302016
Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters
R Garg, N Singh, A Dube
Parasitology 129 (6), 685-691, 2004
292004
Efficacy of human β-casein fragment (54–59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters
P Sharma, N Singh, R Garg, W Haq, A Dube
Peptides 25 (11), 1873-1881, 2004
262004
van Drunen Littel-van den Hurk S, Gerdts V. A novel combination adjuvant platform for human and animal vaccines
R Garg, L Babiuk
Vaccine 35 (35 Pt A), 4486-9, 2017
242017
The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle
M Snider, R Garg, R Brownlie, JV van den Hurk
Vaccine 32 (50), 6758-6764, 2014
232014
The system can't perform the operation now. Try again later.
Articles 1–20